Eli Lilly and Company
CorpDigest
Eli Lilly and Company
Annual Revenue
Last reviewed: 2026-06-03 · By Swet Parvadiya
FY2023 Revenue
$34.1B
▲ 19.6% vs FY2022 ($28.5B)
Eli Lilly and Company reported $34.1B in revenue for fiscal year 2023. This represents a growth of 19.6% compared to the 2022 figure of $28.5B. In 2024, revenue increased to $45.0B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $45.0B | $10.6B | +31.9% |
| FY2023 | $34.1B | — | +19.6% |
| FY2022 | $28.5B | — | +0.8% |
| FY2021 | $28.3B | — | +15.5% |
| FY2020 | $24.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.